Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.

Main|Search|PHGKB


Last Posted: Sep 24, 2017

---

• Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.  
  Chang Shang-Hung et al. JAMA cardiology 2017 Aug (8) 863-870
• Gene Therapy for Atrial Fibrillation in Heart Failure.  
  Arora R et al. Clinical pharmacology and therapeutics 2017 Aug (2) 200-202
• Genetics of Atrial Fibrillation: State of the Art in 2017.  
  Fatkin Diane et al. Heart, lung & circulation 2017 Sep (9) 894-901
• Genomic basis of atrial fibrillation.  
  Bapat Aneesh et al. Heart (British Cardiac Society) 2017 Sep
• Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.  
  da Silva Ananília Medeiros Gomes et al. BioMed research international 2017 20177804763
• Genetic Risk Prediction of Atrial Fibrillation.  
  Lubitz Steven A et al. Circulation 2017 Apr 135(14) 1311-1320
• Update about atrial fibrillation genetics.  
  Pérez-Serra Alexandra et al. Current opinion in cardiology 2017 Feb
• Proteomics of Atrial Fibrillation: Evolving From a Coarse Understanding to a Fine Phenotype.  
  Hyman Matthew C et al. JAMA cardiology 2017 Mar
• Proteomics of Atrial Fibrillation- Evolving From a Coarse Understanding to a Fine Phenotype  
  C Hyman, JAMA Cardiology, March 29, 2017
• Update on hypertrophic cardiomyopathy and a guide to the guidelines.  
  Sen-Chowdhry Srijita et al. Nature reviews. Cardiology 2016 Nov 13(11) 651-675
• Evaluation of a New Genetic Epidemiology Resource: The Intermountain Genealogy Registry.  
  Knight Stacey et al. Human heredity 2016 Jul 81(1) 1-10
• Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals  
  JD Roberts et al, JAMA Cardiology, June 22, 2016
• The “Double” Paradox of Atrial Fibrillation in Black Individuals  
  TS Stamos et al, JAMA Cardiology, June 22, 2016
• Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden.  
  Verhoef T I et al. The pharmacogenomics journal 2016 Jun
• Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.  
  Mitropoulou Christina et al. Pharmacogenomics 2015 Jan 16(2) 137-48
• Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.  
  Shiffman Dov et al. BMC cardiovascular disorders 2015 15(1) 104

more